On the basis of collective evidence, we hypothesised that PXR has tumour suppressor activity and investigated the effects of PXR expression in PXR-negative colon cancer cells in vitro and in vivo (Workman et al, 1998). Here, NR1I2 is linked to malignant colon neoplasm.